WebSyros Pharmaceuticals (SYRS) NASDAQ: SYRS. Stock Analysis Analyst Forecasts Technical Analysis Chart Earnings Dividends Financials Insider Trading Crowd Wisdom Hedge … WebNov 14, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Karen Hunady - Director-Corporate Communications & Investor Relations
Syros Pharmaceuticals, Inc. Common Stock (SYRS)
WebSYRS Dividend History Back to SYRS Overview The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our... WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … himmeli pori
SYRS Stock Price Syros Pharmaceuticals Inc. Stock Quote ... - MarketWatch
WebMar 7, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Chart Morningstar Rating Rating as of Mar 7, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... WebHeadquarters. 35 CambridgePark Drive 4th Floor Cambridge, MA 02140 Tel: (617) 744-1340 WebApr 12, 2024 · How much institutional selling is happening at Syros Pharmaceuticals? Institutional investors have sold a total of 22,154,450 shares in the last 24 months. This volume of shares sold represents approximately $390.15M in transactions. This page (NASDAQ:SYRS) was last updated on 4/3/2024 by MarketBeat.com Staff. himmelitie 7